Breast Cancer Drug That Extends Life By Six Months Gets Go-ahead: Treatment That Reduces Side Effect

Patients had fewer, less severe side effects and reported a better quality of life. Around 10,000 British women have HER2-positive breast cancer diagnosed each year, about one in five of those affected. Paul Ellis, Professor of Cancer Medicine at Kings College London, said: Kadcyla represents a new way of targeting HER2-positive breast cancer, which ultimately means that we could extend patients lives compared to existing chemotherapy treatment. In addition, we should be able to reduce many of my company the symptomatic side effects associated with standard chemotherapy. Mother-of-four bares horrific scars of her battle against cancer... only to lose more than 100 Facebook friends who found powerful images offensive Kadcyla seeks out and kills cancerous cells in a two-stage attack. It attaches to the tumour cell and blocks signals that encourage the cancer to grow and spread, then breaches the outer defences and releases a payload of chemotherapy to destroy it from within. Because its action is so precise, a normally toxic form of chemotherapy can be used but healthy tissue is spared from unnecessary damage. For Breast cancer drug that extends life by six months gets go-ahead: Treatment that reduces side effects will help women with most aggressive form of the disease original version, visit

Radiation Therapy for Breast Cancer

It's also the type most commonly used in cases of breast cancer. External front page beam radiation works by focusing a beam of radiation from a machine to its target, the area of the body affected by cancer. The other type of breast cancer radiation is called brachytherapy. This type delivers radiation to the cancer internally using an implant. In the case of breast cancer, radioactive seeds or pellets -- as small as grains of rice -- are placed inside the breast near the cancer. Brachytherapy can be used alone or with external beam radiation. For Radiation Therapy for Breast Cancer original version, visit

The Problem with Breast Cancer Screenings

Mammograms have long been promoted as the necessary weapon to combat breast cancer, the second leading cause of cancer death in women. The American Cancer Society currently recommends annual mammograms for women age 40 and older. The National Cancer Institute recommends them every one to two years. The Susan G. Komen Foundation, the largest, most well-known breast-cancer organization in the U.S., includes regular screenings as a large part of its mission. However, the new study complicates this assumption. Overdiagnosis can lead to unnecessary, harmful, and expensive treatment, and the tests themselves include small amounts of radiation that can be harmful in heavy doses. For The Problem with Breast Cancer Screenings original version, visit

After Surviving Breast Cancer, Yoga May Be Recovery Key (Op-Ed)

The results, published in the Journal of Clinical Oncology , show that yoga is beneficial in many ways to breast cancer survivors. Yoga provides graded exercise that can be tailored for individuals who have been sedentary, and the postures can be modified to accommodate functional limitations. It is widely known that yoga benefits your health. Many people who practice yoga experience gains in flexibility, feel more relaxed, sleep better, have stronger muscles and also might even see a drop in their blood pressure. What my colleagues and I at The Ohio State University Wexner Medical Center concluded in our study is that inflammation for cancer patients also dropped when they routinely practiced yoga. [ Yoga Holds Benefits for Breast Cancer Survivors ] My study was a randomized, controlled trial (RCT) of 200 women who are breast cancer survivors. I compared a 12-week hatha yoga intervention with a wait-list control condition, which is a group who did not do yoga during the study. For After Surviving Breast Cancer, Yoga May Be Recovery Key (Op-Ed) original version, visit